跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lamosyn 50 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lamosyn 50
Approved
STANDARD
Lamosyn 50
Sun Pharmaceutical Industries Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
58fc8e2991b513a1
Company
Sun Pharmaceutical Industries Limited
Type
Standard
Approval Details
Approval Id
58fc8e2991b513a1
Drug Approval Philippines Name
Lamosyn 50
Product Name
Lamosyn 50
Registration Number
DRP-16296
Brand Name
Lamosyn 50
Generic Name
Lamotrigine
Dosage Form
Tablet
Dosage Strength
50 mg
Manufacturer
Sun Pharmaceutical Industries Limited
Importer
Sun Pharma Philippines, Inc.
Distributor
Sun Pharma Philippines, Inc.
Company Detail Path
/organization/sun-pharmaceutical-industries-limited
Issuance Date
28 January 2025
Expiry Date
28 January 2030
Pharmacologic Category
Anticonvulsant
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
58fc8e2991b513a1
Type
Standard
Back to Philippines FDA Approvals